SCHEMBL3034523

SCHEMBL3034523

NC(=O)c1ccc2cc(C(=O)N(O)Cc3cccc(F)c3)ccc2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.52
PARP10 Q53GL7 1/20 0.52
PARP1 P09874 1/20 0.49
ALDH1A1 P00352 1/20 0.42
HPGD P15428 1/20 0.42
TAS2R14 Q9NYV8 3/20 0.42
NR4A2 P43354 1/20 0.41
LCK P06239 1/20 0.41
MEP1B Q16820 1/20 0.40
PLAU P00749 1/20 0.40
MAPK14 Q16539 1/20 0.40
RIPK1 Q13546 1/20 0.40
CLK1 P49759 1/20 0.39
CLK2 P49760 1/20 0.39
DYRK1A Q13627 1/20 0.39
CLK4 Q9HAZ1 1/20 0.39
DYRK1B Q9Y463 1/20 0.39
MAPK8 P45983 1/20 0.39
SLC1A1 P43005 2/20 0.39
NTRK1 P04629 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3454177 0.88 LCK (0.44) MAOBPARP10PARP1LCKPLAU
SCHEMBL3454219 0.83 MEP1B (0.48) MAOBPARP10PARP1HPGDLCK
SCHEMBL3031503 0.82 PARP1 (0.54) PARP1HPGDTAS2R14MEP1BPLAU
SCHEMBL3454183 0.82 MAPK14 (0.49) MAOBPARP10ALDH1A1LCKPLAU
SCHEMBL3453592 0.81 PARP10 (0.46) PARP10PARP1HPGDPLAU
SCHEMBL3454136 0.78 PARP1 (0.46) MAOBPARP10PARP1MEP1BCLK1
SCHEMBL3454090 0.77 PARP1 (0.53) MAOBPARP10PARP1HPGDLCK
SCHEMBL3453561 0.77 PARP10 (0.49) PARP10PARP1ALDH1A1LCKPLAU
SCHEMBL3455277 0.73 MEN1 (0.49) PARP10PARP1ALDH1A1TAS2R14LCK
SCHEMBL14060956 0.72 LCK (0.62) MAOBPARP10PARP1ALDH1A1LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100216796-A1 N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS KATTAR SOLOMON 2010-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216796-A1 N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS BRDT, AADAC, ACIN1 MAOB 1042/4885PARP10 1130/4885PARP1 957/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.